Trends in testing behaviours for hepatitis C virus infection and associated determinants: Results from population-based laboratory surveillance in Alberta, Canada (1998-2001)

Journal of Viral Hepatitis

Volumn 14, Issue 4, 2007, Pages 249-254

  Jayaraman, G C ^a   Lee, B ^b   Singh, A E ^c   Preiksaitis, J K ^b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^c Provincial Health Office   (Canada)

Author keywords

Canada; Hepatitis B; Hepatitis C; Human immunodeficiency virus; Surveillance; Testing behaviours

Indexed keywords

ADULT; ARTICLE; CANADA; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SEROCONVERSION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ALBERTA; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; POPULATION SURVEILLANCE;

EID: 33947392216     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2006.00820.x     Document Type: Article

References (18)

1. Thomas DL. Hepatitis C epidemiology. Curr Top Microbiol Immunol 2000; 242: 25-41.
2. Thomson BJ, Finch RG. Hepatitis C virus infection. Clin Microbiol Infect 2005; 11: 86-94.
3. Kim WR. The burden of hepatitis C in the United States. Hepatology 2002; 36: S30-S34.
4. Goldman M, Long A. Hepatitis C lookback in Canada. Vox Sang 2000; 78 (Suppl. 2): 249-252.
5. Trepo C, Pradat P. Hepatitis C virus infection in Western Europe. J Hepatol 1999; 31 (Suppl. 1): 80-83.
6. Williams I. Epidemiology of hepatitis C in the United States. Am J Med 1999; 107: 2S-9S.
7. Fuller CM, Ompad DC, Galea S et al. Hepatitis C incidence - a comparison between injection and noninjection drug users in New York City. J Urban Health 2004; 81: 20-24.
8. Patrick DM, Buxton JA, Bigham M et al. Public health and hepatitis C. Can J Public Health 2000; 91 (Suppl. 1): S18-S23.
9. Simonsen L, Kane A, Lloyd J et al. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 1999; 77: 789-800.
10. Hadzic N. Hepatitis C in pregnancy. Arch Dis Child Fetal Neonatal Ed 2001; 84: F201-F204.
11. Alary M, Joly JR, Vincelette J et al. Lack of evidence of sexual transmission of hepatitis C virus in a prospective cohort study of men who have sex with men. Am J Public Health 2005; 95: 502-505.
12. Myung P, Mallette C, Taylor L et al. Sexual transmission of hepatitis C: practical recommendations. Med Health R I 2003; 86: 168-171.
13. Mok J, Pembrey L, Tovo PA et al. When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal Ed 2005; 90: F156-F160.
14. Thomas DL. Hepatitis C and human immunodeficiency virus infection. Hepatology 2002; 36: S201-S209.
15. Rockstroh JK, Spengler U. HIV and hepatitis C virus co-infection. Lancet Infect Dis 2004; 4: 437-444.
16. Alberta Blood-borne Pathogens Surveillance Working Group. Alberta Blood-borne Pathogens Surveillance Report 2003. Edmonton, AB: Alberta Health and Wellness, 2003: 43-45.
17. Bowker SL, Soskolne CL, Houston SC et al. Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) in a Northern Alberta population. Can J Public Health 2004; 95: 188-192.
18. Romanowski B, Preiksaitis J, Campbell P et al. Hepatitis C seroprevalence and risk behaviours in patients attending sexually transmitted disease clinics. Sex Transm Dis 2003; 30: 33-38.